KDR and neoplasm: Other approaches targeting the tumor vasculature to overcome resistance to PD-1/PD-L1 blockade were tested previously, e.g. with anti-VEGFR2 mAbs, which enhanced vascular normalization but did not increase blood vessel density in mouse models of breast and pancreatic cancer (29).